KL and neoplasm: Interestingly, immunohistochemical (IHC) end-point analyses revealed that independent of the tumor source (KL;ASC versus KL;AC), resulting s.c. tumors did not exhibit staining for the AC biomarker nkx2-1 (Fig. 1C).